MicroRNA-23b targets ras GTPase-activating protein SH3 domain-binding protein 2 to alleviate fibrosis and albuminuria in diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 27, Issue 9, 2016, Pages 2597-2608

  Zhao, Binghai ^a   Li, Hongzhi ^a   Liu, Jieting ^a   Han, Pengfei ^b   Zhang, Chunlei ^a   Bai, He ^a   Yuan, Xiaohuan ^a   Wang, Xiaoli ^b   Li, Li ^a   Ma, Hongchuang ^a   Jin, Xiudong ^a   Chu, Yanhui ^a  

^a Medical Research Center   (China)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ 2; ANTAGOMIR; CARRIER PROTEINS AND BINDING PROTEINS; COLLAGEN TYPE 1; COLLAGEN TYPE 4; GLUCOSE; MICRORNA; MICRORNA 23B; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P53; RAS GTPASE ACTIVATING PROTEIN SH3 DOMAIN BINDING PROTEIN 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; G3BP2 PROTEIN, MOUSE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MIRN23B MICRORNA, MOUSE;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS BASEMENT MEMBRANE; GLUCOSE BLOOD LEVEL; HEK293-A CELL LINE; HISTOLOGY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN LEVEL; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; COMPLICATION; ENZYMOLOGY; FIBROSIS; KIDNEY; PATHOLOGY; PHYSIOLOGY;

ALBUMINURIA; ANIMALS; DIABETIC NEPHROPATHIES; FIBROSIS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; RAS GTPASE-ACTIVATING PROTEINS;

EID: 84992496974     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015030300     Document Type: Article

References (45)

1. KatoM, Zhang J,WangM, Lanting L, Yuan H, Rossi JJ, Natarajan R: MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-βeta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 104: 3432-3437, 2007
2. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R: Fibroblasts in kidney fibrosis emerge via endothelial-tomesenchymal transition. J Am Soc Nephrol 19: 2282-2287, 2008
3. Kim MM, Wiederschain D, Kennedy D, Hansen E, Yuan ZM: Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP). Oncogene 26: 4209-4215, 2007
4. Zhang H, Zhang S, He H, Zhao W, Chen J, Shao RG: GAP161 targets and downregulates G3BP to suppress cell growth and potentiate cisplaitin-mediated cytotoxicity to colon carcinoma HCT116 cells. Cancer Sci 103: 1848-1856, 2012
5. Huang A, Yang YM, Yan C, Kaley G, Hintze TH, Sun D: Altered MAPK signaling in progressive deterioration of endothelial function in diabetic mice. Diabetes 61: 3181-3188, 2012
6. Liu W, Lan T, Xie X, Huang K, Peng J, Huang J, Shen X, Liu P, Huang H: S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition. Exp Cell Res 318: 936-943, 2012
7. Chiu J, Xu BY, Chen S, Feng B, Chakrabarti S: Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications. Can J Physiol Pharmacol 86: 365-372, 2008
8. Lopes de Faria JB, Silva KC, Lopes de Faria JM: The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress. Hypertens Res 34: 413-422, 2011
9. Kern TS: Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007: 95103, 2007
10. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP: A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18: 1450-1452, 2004
11. Cargnello M, Tcherkezian J, Dorn JF, Huttlin EL, Maddox PS, Gygi SP, Roux PP: Phosphorylation of the eukaryotic translation initiation factor 4E-transporter (4E-T) by c-Jun N-terminal kinase promotes stress-dependent P-body assembly. Mol Cell Biol 32: 4572-4584, 2012
12. Ng SK, Weissbach R, Ronson GE, Scadden AD: Proteins that contain a functional ZDNA-binding domain localize to cytoplasmic stress granules. Nucleic Acids Res 41: 9786-9799, 2013
13. Kato M, Natarajan R: microRNA cascade in diabetic kidney disease: Big impact initiated by a small RNA. Cell Cycle 8: 3613-3614, 2009
14. Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA: Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 19: 2069-2075, 2008
15. Shi S, Yu L, Chiu C, Sun Y, Chen J, Khitrov G, Merkenschlager M, Holzman LB, Zhang W, Mundel P, Bottinger EP: Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 19: 2159-2169, 2008
16. Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I, Rossi JJ, Natarajan R: TGF-βeta activates Akt kinase through a microRNAdependent amplifying circuit targeting PTEN. Nat Cell Biol 11: 881-889, 2009
17. Wang B, Koh P, Winbanks C, Coughlan MT, McClelland A, Watson A, Jandeleit-Dahm K, Burns WC, Thomas MC, Cooper ME, Kantharidis P: miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes 60: 280-287, 2011
18. Padmashree DG, Swamy NR: Molecular signaling cascade of miRNAs in causing Diabetes Nephropathy. Bioinformation 9: 401-408, 2013
19. Zhu S, Pan W, Song X, Liu Y, Shao X, Tang Y, Liang D, He D, Wang H, Liu W, Shi Y, Harley JB, Shen N, Qian Y: The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-a. Nat Med 18: 1077-1086, 2012
20. Hou J, Lin L, ZhouW, Wang Z,DingG, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhang Q, Zhuang SM, Zheng L, Liang A, Tao W, Cao X: Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19: 232-243, 2011
21. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, Cabili MN, Jaenisch R, Mikkelsen TS, Jacks T, Hacohen N, Bernstein BE, Kellis M, Regev A, Rinn JL, Lander ES: Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458: 223-227, 2009
22. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, ZukO, Amit I, RabaniM, Attardi LD, Regev A, Lander ES, Jacks T, Rinn JL: A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142: 409-419, 2010
23. Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, Manos PD, Datta S, Lander ES, Schlaeger TM, Daley GQ, Rinn JL: Large intergenic non-coding RNARoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 42: 1113-1117, 2010
24. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S, Guenther MG, JohnstonWK,WernigM,NewmanJ,Calabrese JM, Dennis LM, Volkert TL, Gupta S, Love J, Hannett N, Sharp PA, Bartel DP, Jaenisch R, Young RA: ConnectingmicroRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134: 521-533, 2008
25. Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM Jr, HofmainsterC, Alder H,Garofalo M,Di LevaG, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM: Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 18: 367-381, 2010
26. Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, Kim T, Bakàcs A, Alder H, Kaur B, Aqeilan RI, Pichiorri F, Croce CM: Micro-RNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci U S A 109: 5316-5321, 2012
27. Bisio A, De Sanctis V, Del Vescovo V, Denti MA, Jegga AG, Inga A, Ciribilli Y: Identification of new p53 target microRNAs by bioinformatics and functional analysis. BMC Cancer 13: 552, 2013
28. Deshpande SD, Putta S, Wang M, Lai JY, Bitzer M, Nelson RG, Lanting LL, Kato M, Natarajan R: Transforming growth factorb-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes 62: 3151-3162, 2013
29. Kim JN, Chang IY, Kim JH, Kim JW, Park KS, Kim HI, Yoon SP: The role of apurinic/ apyrimidinic endonuclease on the progression of streptozotocin-induced diabetic nephropathy in rats. Acta Histochem 114: 647-652, 2012
30. Godley LA, Kopp JB, Eckhaus M, Paglino JJ, Owens J, Varmus HE: Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev 10: 836-850, 1996
31. BrownleeM: Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001
32. Latronico MV, Catalucci D, Condorelli G: MicroRNA and cardiac pathologies. Physiol Genomics 34: 239-242, 2008
33. Chuang JC, Jones PA: Epigenetics and microRNAs. Pediatr Res 61: 24R-29R, 2007
34. He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531, 2004
35. Ørom UA, Lund AH: Experimental identification of microRNA targets. Gene 451: 1-5, 2010
36. Zhang H, Hao Y, Yang J, Zhou Y, Li J, Yin S, Sun C, Ma M, Huang Y, Xi JJ: Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. Nat Commun 2: 554, 2011
37. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV: c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458: 762-765, 2009
38. Matsuki H, Takahashi M, Higuchi M, Makokha GN, Oie M, Fujii M: Both G3BP1 and G3BP2 contribute to stress granule formation. Genes Cells 18: 135-146, 2013
39. Ward AM, Bidet K, Yinglin A, Ler SG, Hogue K, BlackstockW, Gunaratne J, Garcia-Blanco MA:Quantitativemass spectrometry ofDENV-2 RNA-interacting proteins reveals that the DEAD-box RNA helicase DDX6 binds the DB1 and DB2 39 UTR structures. RNA Biol 8: 1173-1186, 2011
40. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R: MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7: 719-723, 2005
41. Wei J, Shi Y, Hou Y, Ren Y, Du C, Zhang L, Li Y, Duan H: Knockdown of thioredoxininteracting protein ameliorates high glucoseinduced epithelial to mesenchymal transition in renal tubular epithelial cells. Cell Signal 25: 2788-2796, 2013
42. Adhikary L, Chow F, Nikolic-Paterson DJ, Stambe C, Dowling J, Atkins RC, Tesch GH: Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia 47: 1210-1222, 2004
43. Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, Feldman RD, Chakrabarti S: miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications. Diabetes 60: 2975-2984, 2011
44. Xie L, Chen X, Wang L, Qian X, Wang T, Wei J, Yu L, Ding Y, Zhang C, Liu B: Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions. BMC Cancer 10: 591, 2010
45. Taylor CJ, Satoor SN, Ranjan AK, Pereira e Cotta MV, Joglekar MV: A protocol for measurement of noncoding RNA in human serum. Exp Diabetes Res 2012: 168368, 2012